Rhenman & Partners Asset Management Ab Accolade, Inc. Transaction History

Rhenman & Partners Asset Management Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.28 - $18.9 $1.06 Million - $3.78 Million	-200,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.92 - $27.18 $129,200 - $271,800	-10,000 Reduced 4.76%	200,000 $3.51 Million
Q4 2021 Feb 11, 2022	SELL	$21.96 - $42.69 $2.53 Million - $4.91 Million	-115,000 Reduced 35.38%	210,000 $5.52 Million
Q3 2021 Nov 12, 2021	BUY	$41.3 - $54.56 $1.03 Million - $1.36 Million	25,000 Added 8.33%	325,000 $13.7 Million
Q2 2021 Aug 13, 2021	BUY	$38.61 - $55.0 $3.86 Million - $5.5 Million	100,000 Added 50.0%	300,000 $16.3 Million
Q1 2021 May 14, 2021	BUY	$38.1 - $59.09 $1.91 Million - $2.95 Million	50,000 Added 33.33%	200,000 $9.07 Million
Q4 2020 Jan 19, 2021	SELL	$33.26 - $59.72 $55,677 - $99,971	-1,674 Reduced 1.1%	150,000 $6.53 Million
Q3 2020 Oct 13, 2020	BUY	$0.55 - $41.34 $83,420 - $6.27 Million	151,674 New	151,674 $5.9 Million

170

65.8M

61K

566K

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $228M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.